Which has the lower trailing P/E, BIIB or WAT?

BIIB has the lower trailing P/E: BIIB trades at 36.51 and WAT at 99.68. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BIIB or WAT?

Over the past five years, WAT grew revenue faster — BIIB at a -3.19% CAGR versus WAT at 11.70%.

Is BIIB or WAT more profitable?

BIIB runs the higher net margin — BIIB at 8.39% versus WAT at 3.58%.

How have BIIB and WAT total returns compared?

Over the past 10 years, BIIB delivered -4.17% and WAT delivered 9.78% annualized total return. Past performance doesn't predict future results.

Biogen Inc. (BIIB) vs Waters Corporation (WAT)

A side-by-side comparison of Biogen Inc. and Waters Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 6, 2026. Differences are shown without an overall score or investment verdict.

BIIB

Biogen Inc.

$30.48B

$206.28HealthcareDelayed quote: Aug 6, 2026, 4:00 PM EDT

WAT

Waters Corporation

$29.89B

$399.70HealthcareDelayed quote: Aug 6, 2026, 4:00 PM EDT

Total return — BIIB vs WAT

growth of $100 · dividends reinvested · last 30y

BIIB +6728.6%WAT +5088.0%BIIB compounded faster

BIIB WAT

BIIB vs WAT: by the numbers

•BIIB is the larger company ($30.48B vs $29.89B market cap).
•BIIB trades at the lower trailing earnings multiple (36.51 vs 99.68 P/E), one valuation lens rather than an overall verdict.
•BIIB converts more revenue to profit (8.39% vs 3.58% net margin).
•WAT grew revenue faster over the past five years (11.70% vs -3.19% CAGR).

Metrics side by side

Valuation

Metric	BIIB	WAT
P/E ratio	36.51	99.68
Forward P/E	16.23	27.53
P/S ratio	3.08	8.45
P/B ratio	1.63	2.58
PEG ratio	N/A	75.61
EV / EBITDA	21.42	47.20
FCF yield	9.68%	1.01%

Profitability

Metric	BIIB	WAT
Gross margin	67.71%	50.78%
Operating margin	12.79%	28.22%
Net margin	8.39%	3.58%
ROE	4.43%	1.09%
ROIC	6.62%	17.57%

Growth (annualized)

Metric	BIIB	WAT
Revenue CAGR (5Y)	-3.19%	11.70%
EPS CAGR (5Y)	-18.67%	5.16%
FCF CAGR (5Y)	-11.63%	-9.19%
Total return CAGR (5Y)	-9.51%	0.21%

Frequently asked

Which has the lower trailing P/E, BIIB or WAT?: BIIB has the lower trailing P/E: BIIB trades at 36.51 and WAT at 99.68. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BIIB or WAT?: Over the past five years, WAT grew revenue faster — BIIB at a -3.19% CAGR versus WAT at 11.70%.
Is BIIB or WAT more profitable?: BIIB runs the higher net margin — BIIB at 8.39% versus WAT at 3.58%.
How have BIIB and WAT total returns compared?: Over the past 10 years, BIIB delivered -4.17% and WAT delivered 9.78% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BIIB analysis Full WAT analysis Interactive comparison tool

Dig into the metrics

Biogen P/E ratio Waters P/E ratio Biogen dividend yield Waters dividend yield Biogen ROE Waters ROE Biogen operating margin Waters operating margin Biogen revenue growth Waters revenue growth Biogen free cash flow Waters free cash flow

Biogen & Waters appear in these rankings

Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 6, 2026.